» Articles » PMID: 33859294

High-throughput Enrichment and Isolation of Megakaryocyte Progenitor Cells from the Mouse Bone Marrow

Overview
Journal Sci Rep
Specialty Science
Date 2021 Apr 16
PMID 33859294
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Megakaryocytes are a rare population of cells that develop in the bone marrow and function to produce platelets that circulate throughout the body and form clots to stop or prevent bleeding. A major challenge in studying megakaryocyte development, and the diseases that arise from their dysfunction, is the identification, classification, and enrichment of megakaryocyte progenitor cells that are produced during hematopoiesis. Here, we present a high throughput strategy for identifying and isolating megakaryocytes and their progenitor cells from a heterogeneous population of bone marrow samples. Specifically, we couple thrombopoietin (TPO) induction, image flow cytometry, and principal component analysis (PCA) to identify and enrich for megakaryocyte progenitor cells that are capable of self-renewal and directly differentiating into mature megakaryocytes. This enrichment strategy distinguishes megakaryocyte progenitors from other lineage-committed cells in a high throughput manner. Furthermore, by using image flow cytometry with PCA, we have identified a combination of markers and characteristics that can be used to isolate megakaryocyte progenitor cells using standard flow cytometry methods. Altogether, these techniques enable the high throughput enrichment and isolation of cells in the megakaryocyte lineage and have the potential to enable rapid disease identification and diagnoses ahead of severe disease progression.

Citing Articles

The role of PALLD-STAT3 interaction in megakaryocyte differentiation and thrombocytopenia treatment.

Li G, Jiang H, Wang L, Liang T, Ding C, Yang M Haematologica. 2024; 109(11):3693-3704.

PMID: 38813732 PMC: 11532707. DOI: 10.3324/haematol.2024.285242.


Advancing in vivo reprogramming with synthetic biology.

Islam F, Lewis M, Craig J, Leyendecker P, Deans T Curr Opin Biotechnol. 2024; 87:103109.

PMID: 38520824 PMC: 11162311. DOI: 10.1016/j.copbio.2024.103109.


In Vitro Generation of Megakaryocytes from Engineered Mouse Embryonic Stem Cells.

Lewis M, Deans T Methods Mol Biol. 2024; 2774:279-301.

PMID: 38441772 PMC: 11460828. DOI: 10.1007/978-1-0716-3718-0_19.


Programming megakaryocytes to produce engineered platelets for delivering non-native proteins.

Islam F, Javdan S, Lewis M, Craig J, Wu H, Deans T bioRxiv. 2023; .

PMID: 37873465 PMC: 10592833. DOI: 10.1101/2023.10.13.562311.


A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains.

Gutierrez-Barbosa H, Medina-Moreno S, Perdomo-Celis F, Davis H, Coronel-Ruiz C, Zapata J Microorganisms. 2023; 11(6).

PMID: 37375051 PMC: 10300940. DOI: 10.3390/microorganisms11061548.


References
1.
Wilson A, Trumpp A . Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006; 6(2):93-106. DOI: 10.1038/nri1779. View

2.
Haas S, Hansson J, Klimmeck D, Loeffler D, Velten L, Uckelmann H . Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors. Cell Stem Cell. 2015; 17(4):422-34. DOI: 10.1016/j.stem.2015.07.007. View

3.
Kaushansky K, Lok S, Holly R, Broudy V, Lin N, BAILEY M . Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369(6481):568-71. DOI: 10.1038/369568a0. View

4.
Kuter D, Beeler D, Rosenberg R . The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994; 91(23):11104-8. PMC: 45175. DOI: 10.1073/pnas.91.23.11104. View

5.
Laurenti E, Gottgens B . From haematopoietic stem cells to complex differentiation landscapes. Nature. 2018; 553(7689):418-426. PMC: 6555401. DOI: 10.1038/nature25022. View